vivid seats inc - SEAT
SEAT
Close Chg Chg %
1.52 0.01 0.33%
Open Market
1.53
+0.01 (0.33%)
Volume: 574.95K
Last Updated:
Jun 4, 2025, 12:05 PM EDT
Company Overview: vivid seats inc - SEAT
SEAT Key Data
| Open $1.51 | Day Range 1.47 - 1.54 |
| 52 Week Range 1.44 - 5.90 | Market Cap $197.37M |
| Shares Outstanding 129.85M | Public Float 67.33M |
| Beta 0.96 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.02 |
| Yield 0.00% | Dividend $0.23 |
| EX-DIVIDEND DATE Oct 28, 2021 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.52M |
SEAT Performance
| 1 Week | -2.56% | ||
| 1 Month | -43.91% | ||
| 3 Months | -61.81% | ||
| 1 Year | -70.88% | ||
| 5 Years | N/A |
SEAT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
11
Full Ratings ➔
About vivid seats inc - SEAT
Vivid Seats, Inc. operates as an online ticket marketplace, which engages in the provision of different selections of events and tickets in North America. It operates through the following segments: Marketplace and Resale. The Marketplace segment acts as an intermediary between event ticket buyers and ticket sellers. The Resale segment acquires tickets to resell on secondary ticket marketplaces, including its own. Its partners include Caesars Entertainment, RollingStone, Marriott Bonvoy, Capital One, American Airlines and others. The company was founded in 2001 and is headquartered in Chicago, IL.
SEAT At a Glance
Vivid Seats, Inc.
24 East Washington Street
Chicago, Illinois 60602
| Phone | 1-312-291-9966 | Revenue | 775.59M | |
| Industry | Movies/Entertainment | Net Income | 9.43M | |
| Sector | Consumer Services | 2024 Sales Growth | 8.796% | |
| Fiscal Year-end | 12 / 2025 | Employees | 768 | |
| View SEC Filings |
SEAT Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 82.384 |
| Price to Sales Ratio | 1.249 |
| Price to Book Ratio | 2.347 |
| Price to Cash Flow Ratio | 17.958 |
| Enterprise Value to EBITDA | 15.051 |
| Enterprise Value to Sales | 1.914 |
| Total Debt to Enterprise Value | 0.275 |
SEAT Efficiency
| Revenue/Employee | 1,009,877.604 |
| Income Per Employee | 12,272.135 |
| Receivables Turnover | 16.053 |
| Total Asset Turnover | 0.487 |
SEAT Liquidity
| Current Ratio | 0.811 |
| Quick Ratio | 0.765 |
| Cash Ratio | 0.575 |
SEAT Profitability
| Gross Margin | 68.27 |
| Operating Margin | 6.792 |
| Pretax Margin | 2.929 |
| Net Margin | 1.215 |
| Return on Assets | 0.592 |
| Return on Equity | 5.148 |
| Return on Total Capital | 1.409 |
| Return on Invested Capital | 1.794 |
SEAT Capital Structure
| Total Debt to Total Equity | 156.117 |
| Total Debt to Total Capital | 60.955 |
| Total Debt to Total Assets | 24.915 |
| Long-Term Debt to Equity | 154.604 |
| Long-Term Debt to Total Capital | 60.365 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Vivid Seats Inc - SEAT
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 443.04M | 600.27M | 712.88M | 775.59M | |
Sales Growth
| - | +35.49% | +18.76% | +8.80% | |
Cost of Goods Sold (COGS) incl D&A
| 92.94M | 148.24M | 199.36M | 246.09M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 2.32M | 9.90M | 18.00M | 45.94M | |
Depreciation
| 100.00K | 2.77M | 2.22M | 3.40M | |
Amortization of Intangibles
| 2.22M | 7.13M | 15.78M | 42.54M | |
COGS Growth
| - | +59.50% | +34.49% | +23.44% | |
Gross Income
| 350.10M | 452.03M | 513.52M | 529.49M | |
Gross Income Growth
| - | +29.12% | +13.60% | +3.11% | |
Gross Profit Margin
| +79.02% | +75.30% | +72.03% | +68.27% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 272.23M | 368.31M | 419.50M | 476.81M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 272.23M | 368.31M | 419.50M | 476.81M | |
SGA Growth
| +50,470.58% | +35.29% | +13.90% | +13.66% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 38.52M | 1.31M | 8.89M | 6.93M | |
EBIT after Unusual Expense
| 39.35M | 82.42M | 85.13M | 45.75M | |
Non Operating Income/Expense
| (822.00K) | (369.00K) | (685.00K) | 145.00K | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 57.36M | 12.86M | 13.51M | 23.17M | |
Interest Expense Growth
| +9,807.07% | -77.58% | +5.03% | +71.58% | |
Gross Interest Expense
| 57.36M | 12.86M | 13.51M | 23.17M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (18.82M) | 69.19M | 70.94M | 22.72M | |
Pretax Income Growth
| -6.86% | +467.54% | +2.53% | -67.98% | |
Pretax Margin
| -4.25% | +11.53% | +9.95% | +2.93% | |
Income Tax
| 304.00K | (1.59M) | (42.20M) | 8.42M | |
Income Tax - Current - Domestic
| 304.00K | 263.00K | 1.41M | 3.30M | |
Income Tax - Current - Foreign
| - | - | 1.25M | 3.87M | - |
Income Tax - Deferred - Domestic
| - | - | (44.49M) | 5.35M | - |
Income Tax - Deferred - Foreign
| - | (1.85M) | (372.00K) | (4.10M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | 12.84M | - |
Consolidated Net Income
| (6.29M) | 70.78M | 113.14M | 14.30M | |
Minority Interest Expense
| (3.01M) | 42.12M | 38.60M | 4.88M | |
Net Income
| (3.28M) | 28.66M | 74.54M | 9.43M | |
Net Income Growth
| +81.36% | +973.04% | +160.05% | -87.36% | |
Net Margin Growth
| -0.74% | +4.77% | +10.46% | +1.22% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (3.28M) | 28.66M | 74.54M | 9.43M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (3.28M) | 28.66M | 74.54M | 9.43M | |
EPS (Basic)
| -0.0424 | 0.3571 | 0.8042 | 0.0712 | |
EPS (Basic) Growth
| +83.64% | +942.22% | +125.20% | -91.15% | |
Basic Shares Outstanding
| 77.50M | 80.26M | 92.68M | 132.33M | |
EPS (Diluted)
| -0.0424 | 0.3561 | 0.2575 | 0.0562 | |
EPS (Diluted) Growth
| +83.64% | +939.86% | -27.69% | -78.17% | |
Diluted Shares Outstanding
| 77.50M | 198.74M | 198.88M | 209.14M | |
EBITDA
| 80.19M | 93.63M | 112.02M | 98.61M | |
EBITDA Growth
| +14,997.18% | +16.75% | +19.64% | -11.96% | |
EBITDA Margin
| +18.10% | +15.60% | +15.71% | +12.71% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 2.806 | |
| Number of Ratings | 11 | Current Quarters Estimate | -0.034 | |
| FY Report Date | 06 / 2025 | Current Year's Estimate | -0.099 | |
| Last Quarter’s Earnings | -0.049 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.06 | Next Fiscal Year Estimate | -0.027 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 9 | 9 | 9 | 9 |
| Mean Estimate | -0.03 | -0.02 | -0.10 | -0.03 |
| High Estimates | -0.01 | -0.01 | -0.05 | 0.08 |
| Low Estimate | -0.07 | -0.05 | -0.17 | -0.07 |
| Coefficient of Variance | -56.65 | -53.25 | -36.36 | -163.46 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 5 | 5 | 9 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 5 | 5 | 4 |
| UNDERWEIGHT | 1 | 1 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Vivid Seats Inc - SEAT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Vivid Seats Inc - SEAT
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 14, 2025 | Emily Tabak Epstein General Counsel | 122,446 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $3.77 per share | 461,621.42 |
| Mar 14, 2025 | Stefano Langenbacher Chief Technology Officer | 145,347 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Stefano Langenbacher Chief Technology Officer | 79,826 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $3.77 per share | 300,944.02 |
| Mar 14, 2025 | Stanley Chia Chief Executive Officer; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Lawrence C. Fey Chief Financial Officer | 645,998 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Lawrence C. Fey Chief Financial Officer | 95,305 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Lawrence C. Fey Chief Financial Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Lawrence C. Fey Chief Financial Officer | 871,033 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Lawrence C. Fey Chief Financial Officer | 548,039 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Lawrence C. Fey Chief Financial Officer | 531,794 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Stanley Chia Chief Executive Officer; Director | 174,339 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Stanley Chia Chief Executive Officer; Director | 842,164 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Stefano Langenbacher Chief Technology Officer | 290,699 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Emily Tabak Epstein General Counsel | 63,270 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Emily Tabak Epstein General Counsel | 179,547 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Stanley Chia Chief Executive Officer; Director | 868,562 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Emily Tabak Epstein General Counsel | 31,381 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Edward Pickus Chief Accounting Officer | 129,200 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Stanley Chia Chief Executive Officer; Director | 1,514,550 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Stanley Chia Chief Executive Officer; Director | 1,291,996 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |